|
Model Number PED-350-35 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Intracranial Hemorrhage (1891)
|
Event Date 06/24/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
See manufacturer report # 2029214-2021-00781 for the catheter involved in this event.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received a report that when the marksman catheter and pipeline stent were in place, angiography found bleeding.Finally, the blood vessel was closed. the patient did not experience any injury, symptoms, or complications.The devices were prepared and flushed according to the instructions for use (ifu).The patient was undergoing treatment for an unruptured, fusiform aneurysm located in the middle cerebral artery.The max diameter was 13mm, and the neck diameter was 24mm.The patient's vessel tortuosity was minimal/normal.The landing zone was 3.4mm distal and 3.6mm proximal.The access vessel was the femoral artery, which was 7mm in diameter.Dual antiplatelet treatment was not administered.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received indicated the device(s) were fully rinsed with heparin saline per the instructions for use (ifu).There was no resistance experienced.
|
|
Event Description
|
The cause of the bleeding was unknown.It was not related to the device or procedure.The surgeon only said that the blood could not stop, and finally closed the blood vessel.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
H3: the pipeline flex was returned within the marksman catheter.The pipeline pushwire was found to be extending ~50.5cm from hub.The pipeline flex was then removed from the marksman catheter.No bends or kinks were found with the pipeline flex pushwire.The hypotube and ptfe were found to be intact.The proximal bumper, pad, and pad restraint were found intact.The dps sleeves were found to be intact.No damages were found with the tip coil.The proximal and distal braid ends were found to be opened.No other anomalies were observed.Based on the reported information, there is no evidence suggesting that the devices were defective, but rather a procedure related event.This event captures an adverse event.There is no allegation or evidence of potential or confirmed manufacturing issues.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|